MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$2,483K
Net Income
-$10,490K
Net Profit Margin
-422.47%
EPS
-$0.26
Unit: Thousand (K) dollars
Revenue Breakdown
Recurring Non Capital
Capital Equipment
Revenue Breakdown
US
CA
DE
Revenue Breakdown
Transferred At Point In Time
Transferred Over Time
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue (note 12)
2,483
5,337
5,977
5,289
Cost of sales
536
1,505
1,986
1,358
Gross profit
1,947
3,832
3,991
3,931
Research and development
5,654
5,262
4,272
5,418
Selling, general and administrative
7,359
6,591
7,088
7,426
Total operating expenses
13,013
11,853
11,360
12,844
Operating loss
-11,066
-8,021
-7,369
-8,913
Net finance income
336
377
160
122
Net foreign exchange (gain) loss
1,245
616
-939
935
Total other (income) expenses
1,581
993
-779
1,057
Net loss before income taxes
-9,485
-7,028
-8,148
-7,856
Income tax expense
68
27
12
100
Deferred tax recovery
-13
-2
14
21
Total income tax expense
55
25
26
121
Net loss attributed to shareholders for the period
-9,540
-7,053
-8,174
-7,977
Foreign currency translation adjustment
-950
-1,005
275
-808
Net loss and other comprehensive loss for the period
-10,490
-8,058
-7,899
-8,785
Basic EPS
-0.26
0.19
-0.257
0.26
Diluted EPS
-0.26
0.19
-0.257
0.26
Basic Average Shares
36,350,665
36,297,684
30,732,490
30,104,497
Diluted Average Shares
36,350,665
36,297,684
30,732,490
30,104,497
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
3
Net loss and other
comprehensive loss for the...
-$10,490K
(19.20%↑ Y/Y)
US
$1,301K
(-34.19%↓ Y/Y)
DE
$182K
(30.00%↑ Y/Y)
CA
$129K
(37.23%↑ Y/Y)
US
$444K
(-77.54%↓ Y/Y)
CA
$427K
(354.26%↑ Y/Y)
Net loss attributed
to shareholders...
-$9,540K
(39.22%↑ Y/Y)
Foreign currency
translation adjustment
-$950K
(-135.02%↓ Y/Y)
Net foreign
exchange (gain) loss
$1,245K
(157.43%↑ Y/Y)
Net finance income
$336K
(-2.04%↓ Y/Y)
Recurring Non Capital
$1,612K
Capital Equipment
$871K
Net loss before
income taxes
-$9,485K
(39.32%↑ Y/Y)
Total income tax
expense
$55K
(-14.06%↓ Y/Y)
Total other (income)
expenses
$1,581K
(186.63%↑ Y/Y)
Deferred tax recovery
-$13K
(7.14%↑ Y/Y)
Revenue (note 12)
$2,483K
(12.30%↑ Y/Y)
Operating loss
-$11,066K
(19.85%↑ Y/Y)
Income tax expense
$68K
(-12.82%↓ Y/Y)
Gross profit
$1,947K
(20.33%↑ Y/Y)
Cost of sales
$536K
(-9.61%↓ Y/Y)
Total operating
expenses
$13,013K
(-15.63%↓ Y/Y)
Selling, general and
administrative
$7,359K
(-21.09%↓ Y/Y)
Research and development
$5,654K
(-7.28%↓ Y/Y)
Buy us a coffee
Profound Medical Corp. (PROF)
Profound Medical Corp. (PROF)